FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

IT drives changes in QA department

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

As the use of electronic data capture (EDC) systems grows among clinical researchers, quality assurance professionals are being asked to audit software and service vendors. But there are "significant differences" between using a software vendor and a service vendor. Auditing these two different types of vendors (software as a product vs. software as a service) entails different criteria and expectations, says Joseph Knight-McKenna, senior director of quality and regulatory compliance at drug-safety services provider Drug Safety Alliance (DSA), in a presentation planned for last week's Society of Quality Assurance (SQA) annual meeting in San Diego.

From a QA perspective, IT presents a host of gnarly issues: EDC-based data management systems require a different auditing process than paper-based systems. So audits for EDC should be based on computer system validation to ensure that databases are set-up and tested to ensure that the data is cleaned correctly at initial entry, as Randall Basinger of Quintiles explains.

Another issue involves changes in regulatory expectations for projects that use commercial off-the-shelf (COTS) technology in electronic document management. System complexity and the actions of supplier groups have made regulatory signoffs more difficult, says Kim Nitahara of META Solutions. System selection, configuration, validation, and maintenance, as well as the interactions among COTS vendors, consultants, and system integrators, must all be approached with an eye toward regulator scrutiny.

- here's the Drug Safety Alliance release
- see the SQA meeting details
- and check out the SQA website


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about Electronic Data Capture   quality control   Society of Quality Assurance   Drug Safety Alliance